In cardiotoxicity, PET/MR affords an accurate evaluation of cardiovascular morphology, function, and also multi-parametric tissue characterization. A composite of several cardiac imaging parameters provided by the PET/MR scanner is likely to outperform a single parameter or imaging modality in the assessment and prediction of the severity and progression of cardiotoxicity but needing clinical investigations. Of particular interest, a heterogeneity map of single PET and CMR parameters could be perfectly correlated with the PET/MR scanner likely emerging as a promising marker of cardiotoxicity to monitor treatment response. While such functional and structural multiparametric imaging approach with cardiac PET/MR in the assessment and characterization of cardiotoxicity holds much promise, its validity and value in cancer patients treated with chemotherapy and/or radiation still needs to be assessed. The multi-parametric imaging approach with PET/MR, however, is likely to set new standards to develop predictive constellations of parameters for the severity and potential progression of cardiotoxicity that should afford timely and individualized treatment intervention to ascertain myocardial recovery and improved clinical outcome in these high-risk patients.

Original languageEnglish
Pages (from-to)82-84
Number of pages3
JournalInternational Journal of Cardiology
StatePublished - Aug 15 2023


  • Cancer
  • Cardiac magnetic resonance imaging
  • Cardiotoxicity
  • Chemotherapy
  • Oncology
  • Positron emission tomography
  • Radiation
  • Radiotracers


Dive into the research topics of 'Emerging role of PET/MR in the diagnosis and characterization of cardiotoxicity?'. Together they form a unique fingerprint.

Cite this